Cargando…
Long-Term Benefits of Adding a Pedometer to Pulmonary Rehabilitation for COPD: The Randomized Controlled STAR Trial
PURPOSE: This Stay Active after Rehabilitation (STAR) study examined the effects of a pedometer-based behavioral intervention for individuals with COPD during three weeks of inpatient pulmonary rehabilitation (PR) on patients’ physical activity levels six weeks and six months after PR, including ste...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259733/ https://www.ncbi.nlm.nih.gov/pubmed/34239299 http://dx.doi.org/10.2147/COPD.S304976 |
_version_ | 1783718705484529664 |
---|---|
author | Geidl, Wolfgang Carl, Johannes Schuler, Michael Mino, Eriselda Lehbert, Nicola Wittmann, Michael Pfeifer, Klaus Schultz, Konrad |
author_facet | Geidl, Wolfgang Carl, Johannes Schuler, Michael Mino, Eriselda Lehbert, Nicola Wittmann, Michael Pfeifer, Klaus Schultz, Konrad |
author_sort | Geidl, Wolfgang |
collection | PubMed |
description | PURPOSE: This Stay Active after Rehabilitation (STAR) study examined the effects of a pedometer-based behavioral intervention for individuals with COPD during three weeks of inpatient pulmonary rehabilitation (PR) on patients’ physical activity levels six weeks and six months after PR, including steps (primary outcome), moderate-intensity physical activity, and sedentary time as well as patient quality of life, symptoms, and other psychological and clinical variables. PATIENTS AND METHODS: Rehabilitation patients with COPD wore a triaxial accelerometer (ActiGraph wGT3X) for seven days two weeks before (T0) as well as six weeks (T3) and six months (T4) after PR. In addition to the three-week inpatient PR (control group, CG), the randomly allocated intervention group (IG) received a brief pedometer-based behavioral intervention with the application of the following behavior-change techniques: performing the behavior, individual goal-setting, self-monitoring, and feedback. The effects were analyzed using analysis of covariance with an intention-to-treat approach. RESULTS: A total of 327 patients (69% male, age: 58 years, FEV(1) (%): 53.5, six-minute walk distance: 447.8 m) were randomly allocated to either the IG (n = 167) or CG (n = 160). Although both groups increased their daily steps after PR (IG: M(T3-T0) = 1152, CG: M(T3-T0) = 745; IG: M(T4-T0) = 795, CG: M(T4-T0) = 300), the slightly higher increases in daily steps in the IG compared to the CG at T3 (Δ388 steps, d = 0.16) and T4 (Δ458 steps, d = 0.15) were not statistically significant (p > 0.05 for all). Patients in both groups showed moderate to high pre-post-changes in terms of secondary outcomes, but no advantage favoring the IG was found. CONCLUSION: The results show that adding a pedometer-based behavioral intervention to standard German three-week inpatient PR for COPD patients did not result in more physical activity in terms of steps and moderate-intensity physical activity or less sedentary time. However, both groups (IG and CG) showed remarkably enhanced physical activity levels six weeks and six months after PR, as well as improvements in other secondary outcomes (eg, quality of life). |
format | Online Article Text |
id | pubmed-8259733 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-82597332021-07-07 Long-Term Benefits of Adding a Pedometer to Pulmonary Rehabilitation for COPD: The Randomized Controlled STAR Trial Geidl, Wolfgang Carl, Johannes Schuler, Michael Mino, Eriselda Lehbert, Nicola Wittmann, Michael Pfeifer, Klaus Schultz, Konrad Int J Chron Obstruct Pulmon Dis Original Research PURPOSE: This Stay Active after Rehabilitation (STAR) study examined the effects of a pedometer-based behavioral intervention for individuals with COPD during three weeks of inpatient pulmonary rehabilitation (PR) on patients’ physical activity levels six weeks and six months after PR, including steps (primary outcome), moderate-intensity physical activity, and sedentary time as well as patient quality of life, symptoms, and other psychological and clinical variables. PATIENTS AND METHODS: Rehabilitation patients with COPD wore a triaxial accelerometer (ActiGraph wGT3X) for seven days two weeks before (T0) as well as six weeks (T3) and six months (T4) after PR. In addition to the three-week inpatient PR (control group, CG), the randomly allocated intervention group (IG) received a brief pedometer-based behavioral intervention with the application of the following behavior-change techniques: performing the behavior, individual goal-setting, self-monitoring, and feedback. The effects were analyzed using analysis of covariance with an intention-to-treat approach. RESULTS: A total of 327 patients (69% male, age: 58 years, FEV(1) (%): 53.5, six-minute walk distance: 447.8 m) were randomly allocated to either the IG (n = 167) or CG (n = 160). Although both groups increased their daily steps after PR (IG: M(T3-T0) = 1152, CG: M(T3-T0) = 745; IG: M(T4-T0) = 795, CG: M(T4-T0) = 300), the slightly higher increases in daily steps in the IG compared to the CG at T3 (Δ388 steps, d = 0.16) and T4 (Δ458 steps, d = 0.15) were not statistically significant (p > 0.05 for all). Patients in both groups showed moderate to high pre-post-changes in terms of secondary outcomes, but no advantage favoring the IG was found. CONCLUSION: The results show that adding a pedometer-based behavioral intervention to standard German three-week inpatient PR for COPD patients did not result in more physical activity in terms of steps and moderate-intensity physical activity or less sedentary time. However, both groups (IG and CG) showed remarkably enhanced physical activity levels six weeks and six months after PR, as well as improvements in other secondary outcomes (eg, quality of life). Dove 2021-07-02 /pmc/articles/PMC8259733/ /pubmed/34239299 http://dx.doi.org/10.2147/COPD.S304976 Text en © 2021 Geidl et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Geidl, Wolfgang Carl, Johannes Schuler, Michael Mino, Eriselda Lehbert, Nicola Wittmann, Michael Pfeifer, Klaus Schultz, Konrad Long-Term Benefits of Adding a Pedometer to Pulmonary Rehabilitation for COPD: The Randomized Controlled STAR Trial |
title | Long-Term Benefits of Adding a Pedometer to Pulmonary Rehabilitation for COPD: The Randomized Controlled STAR Trial |
title_full | Long-Term Benefits of Adding a Pedometer to Pulmonary Rehabilitation for COPD: The Randomized Controlled STAR Trial |
title_fullStr | Long-Term Benefits of Adding a Pedometer to Pulmonary Rehabilitation for COPD: The Randomized Controlled STAR Trial |
title_full_unstemmed | Long-Term Benefits of Adding a Pedometer to Pulmonary Rehabilitation for COPD: The Randomized Controlled STAR Trial |
title_short | Long-Term Benefits of Adding a Pedometer to Pulmonary Rehabilitation for COPD: The Randomized Controlled STAR Trial |
title_sort | long-term benefits of adding a pedometer to pulmonary rehabilitation for copd: the randomized controlled star trial |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259733/ https://www.ncbi.nlm.nih.gov/pubmed/34239299 http://dx.doi.org/10.2147/COPD.S304976 |
work_keys_str_mv | AT geidlwolfgang longtermbenefitsofaddingapedometertopulmonaryrehabilitationforcopdtherandomizedcontrolledstartrial AT carljohannes longtermbenefitsofaddingapedometertopulmonaryrehabilitationforcopdtherandomizedcontrolledstartrial AT schulermichael longtermbenefitsofaddingapedometertopulmonaryrehabilitationforcopdtherandomizedcontrolledstartrial AT minoeriselda longtermbenefitsofaddingapedometertopulmonaryrehabilitationforcopdtherandomizedcontrolledstartrial AT lehbertnicola longtermbenefitsofaddingapedometertopulmonaryrehabilitationforcopdtherandomizedcontrolledstartrial AT wittmannmichael longtermbenefitsofaddingapedometertopulmonaryrehabilitationforcopdtherandomizedcontrolledstartrial AT pfeiferklaus longtermbenefitsofaddingapedometertopulmonaryrehabilitationforcopdtherandomizedcontrolledstartrial AT schultzkonrad longtermbenefitsofaddingapedometertopulmonaryrehabilitationforcopdtherandomizedcontrolledstartrial |